Trader consensus implies a 70% probability that the CDC will not issue any Level 4 Travel Health Notice—its highest alert for very high-risk situations with life-threatening disease transmission—by December 31, 2026, reflecting the current absence of such warnings and stable epidemiological indicators. As of April 2026, CDC reports no active Level 4 notices, with recent Level 3 alerts limited to isolated threats like meningococcal disease in the Democratic Republic of the Congo and chikungunya in Mayotte, showing no signs of escalation per official surveillance. Avian influenza A(H5N1) persists with sporadic human cases lacking sustained person-to-person transmission, while mpox clade I outbreaks remain regionally contained with low U.S. risk, per CDC and WHO data. Ongoing monitoring could shift odds if unexpected surges occur, with routine updates expected weekly.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้วCDC issues Level 4 warning by December 31?
CDC issues Level 4 warning by December 31?
$70,268 ปริมาณ
$70,268 ปริมาณ
Dec 31, 2026
$70,268 ปริมาณ
$70,268 ปริมาณ
Dec 31, 2026
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus implies a 70% probability that the CDC will not issue any Level 4 Travel Health Notice—its highest alert for very high-risk situations with life-threatening disease transmission—by December 31, 2026, reflecting the current absence of such warnings and stable epidemiological indicators. As of April 2026, CDC reports no active Level 4 notices, with recent Level 3 alerts limited to isolated threats like meningococcal disease in the Democratic Republic of the Congo and chikungunya in Mayotte, showing no signs of escalation per official surveillance. Avian influenza A(H5N1) persists with sporadic human cases lacking sustained person-to-person transmission, while mpox clade I outbreaks remain regionally contained with low U.S. risk, per CDC and WHO data. Ongoing monitoring could shift odds if unexpected surges occur, with routine updates expected weekly.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
ตลาดเปิดเมื่อ: Jan 19, 2026, 3:15 PM ET
ปริมาณการซื้อขาย
$70,268วันสิ้นสุด
Dec 31, 2026ตลาดเปิดเมื่อ
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus implies a 70% probability that the CDC will not issue any Level 4 Travel Health Notice—its highest alert for very high-risk situations with life-threatening disease transmission—by December 31, 2026, reflecting the current absence of such warnings and stable epidemiological indicators. As of April 2026, CDC reports no active Level 4 notices, with recent Level 3 alerts limited to isolated threats like meningococcal disease in the Democratic Republic of the Congo and chikungunya in Mayotte, showing no signs of escalation per official surveillance. Avian influenza A(H5N1) persists with sporadic human cases lacking sustained person-to-person transmission, while mpox clade I outbreaks remain regionally contained with low U.S. risk, per CDC and WHO data. Ongoing monitoring could shift odds if unexpected surges occur, with routine updates expected weekly.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
ปริมาณการซื้อขาย
$70,268วันสิ้นสุด
Dec 31, 2026ตลาดเปิดเมื่อ
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus implies a 70% probability that the CDC will not issue any Level 4 Travel Health Notice—its highest alert for very high-risk situations with life-threatening disease transmission—by December 31, 2026, reflecting the current absence of such warnings and stable epidemiological indicators. As of April 2026, CDC reports no active Level 4 notices, with recent Level 3 alerts limited to isolated threats like meningococcal disease in the Democratic Republic of the Congo and chikungunya in Mayotte, showing no signs of escalation per official surveillance. Avian influenza A(H5N1) persists with sporadic human cases lacking sustained person-to-person transmission, while mpox clade I outbreaks remain regionally contained with low U.S. risk, per CDC and WHO data. Ongoing monitoring could shift odds if unexpected surges occur, with routine updates expected weekly.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย